Scott Robert Peterson

This profile gathers the share dealings of Scott Robert Peterson in Cascadian Therapeutics, Inc. The record holds 3 filings, for trades running from 11 January 2018 to 9 March 2018.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

On 13 March 2018 came the latest disclosure, a transaction in Cascadian Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 5 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.